TABLE 2

Management Site, Level of Health Care Received, Outcome, and Duration of Clinical Effects Associated With Nicotine and Tobacco Product Exposures Among Children Younger Than 6 Years, NPDS, January 2012 to April 2015

CharacteristicsType of Nicotine and Tobacco ProductTotal, n (%a)
E-cigarette, n (%a)Cigarette, n (%a)Other, n (%a)Unknown, n (%a)
Management site
 Managed on site (non-HCF)2238 (54.2)14 623 (83.5)3453 (72.3)1802 (66.2)22 116 (75.9)
 Patient was referred by PCC to an HCF 972 (23.5)1508 (8.6)858 (18.0)494 (18.1)3832 (13.1)
 Patient already in (en route to) HCF when PCC called875 (21.2)1160 (6.6)397 (8.3)403 (14.8)2835 (9.7)
 Other18 (0.4)54 (0.3)20 (0.4)9 (0.3)101 (0.3)
 Unknown25 (0.6)167 (1.0)50 (1.0)15 (0.6)257 (0.9)
 Total (row %b)4128 (14.2)17 512 (60.1)4778 (16.4)2723 (9.3)29 141 (100.0)
Level of health care received
 Admitted to HCF64 (1.6)53 (0.3)16 (0.3)37 (1.4)170 (0.6)
  Admitted to noncritical care unit40 (1.0)27 (0.2)11 (0.2)26 (1.0)104 (0.4)
  Admitted to critical care unit24 (0.6)26 (0.1)5 (0.1)11 (0.4)66 (0.2)
 No HCF treatment received2281 (55.3)14 844 (84.8)3523 (73.7)1826 (67.1)22 474 (77.1)
 Treated/evaluated and released1435 (34.8)1926 (11.0)844 (17.7)640 (23.5)4845 (16.6)
 Patient lost to follow-up/left against medical advice218 (5.3)433 (2.5)200 (4.2)134 (4.9)985 (3.4)
 Patient refused referral/did not arrive at HCF130 (3.1)256 (1.5)195 (4.1)86 (3.2)667 (2.3)
 Total (row %b)4128 (14.2)17 512 (60.1)4778 (16.4)2723 (9.3)29 141 (100.0)
Outcome
 Severe outcome77 (1.8)127 (0.7)104 (2.2)47 (1.8)355 (1.2)
  Moderate effect71 (1.7)125 (0.7)103 (2.2)45 (1.7)344 (1.2)
  Major effect5 (0.1)2 (0.0)1 (0.0)2 (0.1)10 (0.0)
  Death1 (0.0)0 (0.0)0 (0.0)0 (0.0)1 (0.0)
 Minor effect918 (22.2)3021 (17.3)1419 (29.7)530 (19.5)5888 (20.2)
 No effect1922 (46.6)6046 (34.5)1489 (31.2)963 (35.4)10 420 (35.8)
 Not followed (minimal toxicity)824 (20.0)6826 (39.0)1352 (28.3)921 (33.8)9923 (34.1)
 Unable to follow (potentially toxic)273 (6.6)658 (3.8)284 (5.9)183 (6.7)1398 (4.8)
 Not followed (nontoxic)114 (2.8)834 (4.8)130 (2.7)79 (2.9)1157 (4.0)
 Total (row %b)4128 (14.2)17 512 (60.1)4778 (16.4)2723 (9.3)29 141 (100.0)
Duration of clinical effects
 ≤2 h648 (65.2)2393 (76.0)1107 (72.7)384 (66.6)4532 (72.6)
 >2 h, ≤8 h277 (27.9)545 (17.3)342 (22.5)152 (26.3)1316 (21.1)
 >8 h, ≤24 h37 (3.7)75 (2.4)21 (1.4)21 (3.6)154 (2.5)
 >24 h, ≤3 d3 (0.3)5 (0.2)3 (0.2)3 (0.5)14 (0.2)
 Anticipated permanent0 (0.0)1 (0.0)0 (0.0)0 (0.0)1 (0.0)
 Unknown29 (2.9)129 (4.1)50 (3.3)17 (2.9)225 (3.6)
 Total (row %b)994 (15.9)3148 (50.4)1523 (24.4)577 (9.2)6242 (100.0)
  • a Column percentages may not sum to 100.0% due to rounding error.

  • b Row percentages may not sum to 100.0% due to rounding error.